ABOUT US
Mission Statement
Our mission is
To advance the understanding of Pick’s disease, one of the most rare forms of dementia; To create the world’s largest cohort of postmortem Pick’s disease samples and biospecimens; To conduct genetic studies and determine disease etiology and pathogenesis; To inform into the development of improved therapies for patients.
Our Goals
Research - To conduct multi-omics research studies on the largest Pick’s disease cohort described to date.
Discovery - To support discovery of Pick’s disease risk factors, pathophysiology, and underlining disease mechanisms with the aim of improving patient outcomes.
Education - To provide education for researchers and physicians.
Awareness - To increase awareness of Pick’s disease.
Consortium Sites
If you are interested in becoming part of the PIC, please contact our Consortium directors.
U. S. Collaborators
Canadian Collaborators
European and Australian Collaborators
Consortium Directors
Owen A. Ross, Ph.D.
Mayo Clinic Florida, USA
Jonathan Rohrer, Ph.D.
UCL, UK
Executive Committee
Owen A. Ross, Ph.D.
Mayo Clinic Florida, USA
Rosa Rademakers, Ph.D.
University of Antwerp, Belgium
Jonathan Rohrer, Ph.D, FRCP.
UCL, UK
John Hardy, Ph.D.
UCL, UK
Shanu F. Roemer, M.D
Mayo Clinic Florida, USA
Dennis W. Dickson, M.D
Mayo Clinic Florida, USA
Rebecca Valentino, Ph.D.
Mayo Clinic Florida, USA
William Scotton, MBioch, MBBS, Ph.D.
UCL, UK